NASDAQ:CME

CME Group Stock Forecast, Price & News

$213.25
+1.12 (+0.53 %)
(As of 08/2/2021 11:28 AM ET)
Add
Compare
Today's Range
$212.40
$213.84
50-Day Range
$206.22
$218.85
52-Week Range
$146.89
$221.82
Volume18,372 shs
Average Volume1.47 million shs
Market Capitalization$76.58 billion
P/E Ratio39.86
Dividend Yield1.70%
Beta0.43
30 days | 90 days | 365 days | Advanced Chart
Receive CME News and Ratings via Email

Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.


CME Group logo

About CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.32 out of 5 stars

Finance Sector

405th out of 2,042 stocks

Security & Commodity Brokers, Dealers, Exchanges & Services Industry

5th out of 21 stocks

Analyst Opinion: 1.1Community Rank: 4.3Dividend Strength: 2.5Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











CME Group (NASDAQ:CME) Frequently Asked Questions

Is CME Group a buy right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 2 sell ratings, 8 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View analyst ratings for CME Group
or view top-rated stocks.

What stocks does MarketBeat like better than CME Group?

Wall Street analysts have given CME Group a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CME Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is CME Group's next earnings date?

CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for CME Group
.

How were CME Group's earnings last quarter?

CME Group Inc. (NASDAQ:CME) released its quarterly earnings results on Wednesday, July, 28th. The financial services provider reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.59 by $0.05. CME Group had a trailing twelve-month return on equity of 8.33% and a net margin of 41.64%.
View CME Group's earnings history
.

How has CME Group's stock price been impacted by Coronavirus?

CME Group's stock was trading at $194.6750 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CME stock has increased by 9.5% and is now trading at $213.25.
View which stocks have been most impacted by COVID-19
.

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group announced a quarterly dividend on Wednesday, May 5th. Investors of record on Thursday, June 10th will be paid a dividend of $0.90 per share on Friday, June 25th. This represents a $3.60 dividend on an annualized basis and a yield of 1.69%. The ex-dividend date of this dividend is Wednesday, June 9th.
View CME Group's dividend history
.

Is CME Group a good dividend stock?

CME Group pays an annual dividend of $3.60 per share and currently has a dividend yield of 1.70%. CME Group does not yet have a strong track record of dividend growth. The dividend payout ratio of CME Group is 53.57%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME Group will have a dividend payout ratio of 49.86% next year. This indicates that CME Group will be able to sustain or increase its dividend.
View CME Group's dividend history.

What price target have analysts set for CME?

14 brokers have issued 1 year price targets for CME Group's stock. Their forecasts range from $135.00 to $235.00. On average, they anticipate CME Group's stock price to reach $200.83 in the next year. This suggests that the stock has a possible downside of 5.8%.
View analysts' price targets for CME Group
or view top-rated stocks among Wall Street analysts.

Who are CME Group's key executives?

CME Group's management team includes the following people:
  • Terrence A. Duffy, Executive Chairman & Chief Executive Officer
  • Julie Holzrichter, Chief Operating Officer & Senior Managing Director (LinkedIn Profile)
  • John William Pietrowicz, Chief Financial Officer & Senior Managing Director
  • Kevin Dean Kometer, Chief Information Officer & Senior MD
  • Kendal Vroman, Senior MD-International & Optimization Services

What is Terry Duffy's approval rating as CME Group's CEO?

144 employees have rated CME Group CEO Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among CME Group's employees.

Who are some of CME Group's key competitors?

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), The Walt Disney (DIS), Visa (V), Netflix (NFLX), The Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

What is CME Group's stock symbol?

CME Group trades on the NASDAQ under the ticker symbol "CME."

Who are CME Group's major shareholders?

CME Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Alliancebernstein L.P. (0.73%), Sarasin & Partners LLP (0.52%), Cantillon Capital Management LLC (0.48%), Sumitomo Mitsui Trust Holdings Inc. (0.33%), Intermede Investment Partners Ltd (0.27%) and Aegon Asset Management UK PLC (0.14%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends for CME Group
.

Which major investors are selling CME Group stock?

CME stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Alliancebernstein L.P., State of Alaska Department of Revenue, Aegon Asset Management UK PLC, Cantillon Capital Management LLC, Kornitzer Capital Management Inc. KS, Manning & Napier Group LLC, and Exchange Traded Concepts LLC. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, and Terrence A Duffy.
View insider buying and selling activity for CME Group
or view top insider-selling stocks.

Which major investors are buying CME Group stock?

CME stock was acquired by a variety of institutional investors in the last quarter, including Rathbone Brothers plc, MUFG Securities EMEA plc, Intermede Investment Partners Ltd, Sarasin & Partners LLP, Marathon Asset Management LLP, Calamos Advisors LLC, IFM Investors Pty Ltd, and Dupont Capital Management Corp.
View insider buying and selling activity for CME Group
or or view top insider-buying stocks.

How do I buy shares of CME Group?

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CME Group's stock price today?

One share of CME stock can currently be purchased for approximately $213.25.

How much money does CME Group make?

CME Group has a market capitalization of $76.58 billion and generates $4.88 billion in revenue each year. The financial services provider earns $2.11 billion in net income (profit) each year or $6.72 on an earnings per share basis.

How many employees does CME Group have?

CME Group employs 4,370 workers across the globe.

When was CME Group founded?

CME Group was founded in 1848.

What is CME Group's official website?

The official website for CME Group is www.cmegroup.com.

Where are CME Group's headquarters?

CME Group is headquartered at 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606.

How can I contact CME Group?

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at (312) 930-1000 or via email at [email protected]


This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.